黑山的前列腺癌死亡率趋势1990-2018年
Mirjana Nedovic Vukovic1,2, Milos Bojic2,3, Marina Jaksic2,4
1Center for Health System Evidence and Research in Public Health, Institute of Public Health of Montenegro, Podgorica, Montenegro.
Iranian journal of public health
|November 24, 2025
概括
黑山的前列腺癌死亡率从1990年到2018年每年显著增加2.4%,特别是在75-84岁的男性中. 这突显了加强预防和早期检测策略的迫切需要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 前列腺癌是全球癌症死亡的主要原因,在许多国家造成大量死亡.
- 2020年,前列腺癌在全球估计造成375,304人死亡,死亡率为每10万男性7.7人.
- 它是48个国家的癌症死亡的主要原因,强调其对全球健康的影响.
研究的目的:
- 分析黑山前列腺癌死亡率趋势.
- 评估1990年至2018年间前列腺癌死亡率的变化.
- 确定在黑山受前列腺癌死亡率影响最大的特定年龄组.
主要方法:
- 使用回归技术,包括连接点,线性和波松回归,用于趋势评估.
- 收集和分析了1990年至2018年的黑山前列腺癌死亡率数据.
- 将年龄标准化应用于世界标准人口,以准确估计趋势.
主要成果:
- 在1990年至2018年期间,黑山共记录了1184例前列腺癌死亡.
- 前列腺癌死亡率呈现出2.4%的统计学上显著的年增长 (AAPC=2.4%,P<0.001).
- 75-84岁男性的死亡率显著增加 (每年2.7%,P<0.001),65-74岁男性的死亡率显著增加 (每年1.1%,P=0.452).
结论:
- 观察到的前列腺癌死亡率上升趋势需要改善预防,查和早期诊断措施.
- 应特别注意老年男性人口,特别是75岁及以上的人群.
- 必须加强有效的治疗策略,以应对黑山不断上升的死亡率.
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K


